Switch theme
Sign up to access all valuation multiples
Shanghai Microport Endovascular Medtech Co Ltd is primarily engaged in the development, production and sales of medical devices for aortic and peripheral vascular interventions.
2012
n/a
LTM Revenue $175M
LTM EBITDA $91.9M
$1.2B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
MicroPort has a last 12-month revenue of $175M and a last 12-month EBITDA of $91.9M.
In the most recent fiscal year, MicroPort achieved revenue of $166M and an EBITDA of $97.0M.
MicroPort expects next 12-month revenue of XXX and NTM EBITDA of XXX
See MicroPort valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $164M | $166M | XXX | XXX | XXX |
| Gross Profit | $92.9M | $125M | XXX | XXX | XXX |
| Gross Margin | 57% | 75% | XXX | XXX | XXX |
| EBITDA | $84.0M | $97.0M | XXX | XXX | XXX |
| EBITDA Margin | 51% | 58% | XXX | XXX | XXX |
| Net Profit | $49.2M | $67.8M | XXX | XXX | XXX |
| Net Margin | 30% | 41% | XXX | XXX | XXX |
| Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, MicroPort's stock price is CNY 89 (or $12).
MicroPort has current market cap of CNY 11.0B (or $1.5B), and EV of CNY 8.8B (or $1.2B).
See MicroPort trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1.2B | $1.5B | XXX | XXX | XXX | XXX | $0.58 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, MicroPort has market cap of $1.5B and EV of $1.2B.
MicroPort's trades at 7.0x LTM EV/Revenue multiple, and 13.3x LTM EBITDA.
Analysts estimate MicroPort's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for MicroPort and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $1.2B | XXX | XXX | XXX |
| EV/Revenue | 7.3x | XXX | XXX | XXX |
| EV/EBITDA | 12.6x | XXX | XXX | XXX |
| P/E | 21.9x | XXX | XXX | XXX |
| P/E/Growth | 1.2x | XXX | XXX | XXX |
| EV/FCF | 54.9x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpMicroPort's NTM/LTM revenue growth is 20%
MicroPort's revenue per employee for the last fiscal year averaged n/a, while opex per employee averaged n/a for the same period.
Over next 12 months, MicroPort's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate MicroPort's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for MicroPort and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 2% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 58% | XXX | XXX | XXX | XXX |
| EBITDA Growth | 16% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 78% | XXX | XXX | XXX | XXX |
| Revenue per Employee | n/a | XXX | XXX | XXX | XXX |
| Opex per Employee | n/a | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 7% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 3% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 8% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 26% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
MicroPort acquired XXX companies to date.
Last acquisition by MicroPort was XXXXXXXX, XXXXX XXXXX XXXXXX . MicroPort acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was MicroPort founded? | MicroPort was founded in 2012. |
| Where is MicroPort headquartered? | MicroPort is headquartered in China. |
| Is MicroPort publicy listed? | Yes, MicroPort is a public company listed on SHG. |
| What is the stock symbol of MicroPort? | MicroPort trades under 688016 ticker. |
| When did MicroPort go public? | MicroPort went public in 2019. |
| Who are competitors of MicroPort? | Similar companies to MicroPort include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of MicroPort? | MicroPort's current market cap is $1.5B |
| What is the current revenue of MicroPort? | MicroPort's last 12-month revenue is $175M. |
| What is the current EBITDA of MicroPort? | MicroPort's last 12-month EBITDA is $91.9M. |
| What is the current EV/Revenue multiple of MicroPort? | Current revenue multiple of MicroPort is 7.0x. |
| What is the current EV/EBITDA multiple of MicroPort? | Current EBITDA multiple of MicroPort is 13.3x. |
| What is the current revenue growth of MicroPort? | MicroPort revenue growth between 2023 and 2024 was 2%. |
| Is MicroPort profitable? | Yes, MicroPort is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
